ArticleFrontiers in neurology2025
Global burden and projections of stroke and its subtypes attributable to high alcohol use during 1990-2021: insights from the global burden of disease study 2021.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stroke represents a critical public health challenge with far-reaching global implications for human health. In this study, we seek to characterize the global trends in the burden of stroke attributable to high alcohol use from 1990 to 2021 and investigate its associations with socioeconomic status. Methods: Data on the burden of stroke attributable to high alcohol use were derived from the Global Burden of Disease (GBD) study. The main evaluation indicators include mortality, disability-adjusted life years (DALYs), age-standardized mortality rates (ASMR), and age-standardized DALY rates (ASDR). Trends in disease burden across genders, age groups, and regions were analyzed. Decomposition, frontier, and forecasting analyses were also conducted for the disease. Results: In 2021, stroke attributable to high alcohol consumption remain a substantial global health burden, accounting for 253,625 deaths (95% UI: 53,445-506,300) and 6,003,243 DALYs (95% UI: 1,323,435-11,423,164) worldwide, respectively. ASMR and ASDR for stroke attributable to high alcohol consumption show a global decline, with an EAPC of -1.81 (95% CI: -1.88 to -1.75) for ASMR and -1.63 (95% CI: -1.70 to -1.56) for ASDR. Findings reveal that in global, high, high-middle and middle SDI regions, epidemiological changes are the primary drivers of decline in mortality and DALYs for disease burden. By 2030, the ASMR for high alcohol use-attributable stroke is projected to decline from 4.3 per 100,000 in 2021 to 4.15 per 100,000, while the ASDR is forecast to decrease from 98 per 100,000 in 2021 to 95 per 100,000. Conclusion: In summary, ASMR and ASDR for stroke attributable to high alcohol consumption decline globally, and in most regions from 1990 to 2021. Relevant countries and institutions should continue to attach great importance to the impact of this disease and formulate targeted policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.